Ambeed.cn

首页 / / / / BAX-IN-1

BAX-IN-1 {[allProObj[0].p_purity_real_show]}

货号:A1720652 Ambeed 开学季,买赠积分,赢豪礼

BAX-IN-1是一种潜在的 Bcl-2 相关蛋白 (BAX) 的选择性抑制剂。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
BAX-IN-1 化学结构 CAS号:331261-91-7
BAX-IN-1 化学结构
CAS号:331261-91-7
BAX-IN-1 3D分子结构
CAS号:331261-91-7
BAX-IN-1 化学结构 CAS号:331261-91-7
BAX-IN-1 3D分子结构 CAS号:331261-91-7
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

BAX-IN-1 纯度/质量文件 产品仅供科研

货号:A1720652 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JACS Au, 2024. Ambeed. [ A148168 ]
JMC, 2024. Ambeed. [ A187643 ]
JMC, 2024. Ambeed. [ A341145 , A633512 , A607865 , A167774 ]
Biomacromolecules, 2024. Ambeed. [ A110759 ]
Biomacromolecules, 2024. Ambeed. [ A203543 ]
更多 >
产品名称 Bax Bcl-2 Bcl-B Bcl-w Bcl-xL Bfl-1 Mcl-1 其他靶点 纯度
BTSA1 {[allProObj[0].p_purity_real_show]}
HA14-1 +

Bcl-2, IC50: 9 μM

{[allProObj[0].p_purity_real_show]}
Venetoclax ++++

Bcl-2, Ki: <0.01 nM

{[allProObj[0].p_purity_real_show]}
Navitoclax {[allProObj[0].p_purity_real_show]}
Obatoclax Mesylate +++

Bcl-2, Ki: 0.22 μM

{[allProObj[0].p_purity_real_show]}
ABT-737 +++

Bcl-2, EC50: 30.3 nM

+

Bcl-B, EC50: 1.82 μM

+++

Bcl-w, EC50: 197.8 nM

+++

Bcl-xL, EC50: 78.7 nM

{[allProObj[0].p_purity_real_show]}
Gambogic Acid +

Bfl-1, IC50: 1.06 μM

Bcl-2, IC50: 1.21 μM

++

Bcl-B, IC50: 0.66 μM

++++

Bcl-w, IC50: 0.02 μM

+

Bcl-xL, IC50: 1.47 μM

+

Bfl-1, IC50: 1.06 μM

++

Mcl-1, IC50: 0.79 μM

Caspase {[allProObj[0].p_purity_real_show]}
BH3I-1 +

BH3-Bcl-xL interaction, Ki: 2.4 μM

{[allProObj[0].p_purity_real_show]}
A-1331852 ++++

Bcl-xL, Ki: <0.01 nM

{[allProObj[0].p_purity_real_show]}
A-1210477 ++++

MCL-1, IC50: 26.2 nM

{[allProObj[0].p_purity_real_show]}
Maritoclax {[allProObj[0].p_purity_real_show]}
TW-37 +++

Bcl-2, Ki: 0.29 μM

+

Bcl-xL, Ki: 1.11 μM

+++

Mcl-1, Ki: 0.26 μM

{[allProObj[0].p_purity_real_show]}
UMI-77 ++

Mcl-1, Ki: 490 nM

{[allProObj[0].p_purity_real_show]}
(R)-(-)-Gossypol acetic acid ++

Bcl-2, Ki: 0.32 μM

++

Bcl-xL, Ki: 0.48 μM

+++

Mcl-1, Ki: 0.18 μM

{[allProObj[0].p_purity_real_show]}
Sabutoclax ++

Bfl-1, IC50: 0.62 μM

Bcl-2, IC50: 0.32 μM

++

Bcl-xL, IC50: 0.31 μM

++

Bfl-1, IC50: 0.62 μM

+++

Mcl-1, IC50: 0.20 μM

{[allProObj[0].p_purity_real_show]}
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。
产品名称 VEGFR1 VEGFR2 VEGFR3 其他靶点 纯度
Motesanib Diphosphate ++++

VEGFR1, IC50: 2 nM

++++

VEGFR2, IC50: 3 nM

VEGFR2/Flk1, IC50: 3 nM

+++

VEGFR3, IC50: 6 nM

PDGFR,RET {[allProObj[0].p_purity_real_show]}
Tivozanib ++

VEGFR1, IC50: 30 nM

+++

VEGFR2, IC50: 6.5 nM

++

VEGFR3, IC50: 15 nM

{[allProObj[0].p_purity_real_show]}
Brivanib +

VEGFR1, IC50: 380 nM

++

VEGFR2, IC50: 25 nM

Flk1, IC50: 25 nM

{[allProObj[0].p_purity_real_show]}
Regorafenib +++

VEGFR1, IC50: 13 nM

+++

VEGFR2, IC50: 4.2 nM

+

VEGFR3, IC50: 46 nM

RET {[allProObj[0].p_purity_real_show]}
Pazopanib +++

VEGFR1, IC50: 10 nM

++

VEGFR2, IC50: 30 nM

+

VEGFR3, IC50: 47 nM

FGFR,PDGFR,c-Kit {[allProObj[0].p_purity_real_show]}
Sitravatinib +++

VEGFR1 (FLT1), IC50: 6 nM

+++

VEGFR2 (KDR), IC50: 5 nM

++++

VEGFR3 (FLT4), IC50: 2 nM

{[allProObj[0].p_purity_real_show]}
Foretinib +++

VEGFR1/FLT1, IC50: 6.8 nM

++++

KDR, IC50: 0.86 nM

++++

VEGFR3/FLT4, IC50: 2.8 nM

Tie-2 {[allProObj[0].p_purity_real_show]}
MGCD-265 analog ++++

VEGFR1, IC50: 3 nM

++++

VEGFR2, IC50: 3 nM

++++

VEGFR3, IC50: 4 nM

Tie-2 {[allProObj[0].p_purity_real_show]}
Lactate +++

VEGFR1/FLT1, IC50: 10 nM

+++

VEGFR2/Flk1, IC50: 13 nM

+++

VEGFR3/FLT4, IC50: 8 nM

c-Kit,FLT3 {[allProObj[0].p_purity_real_show]}
AEE788 +

FLT1, IC50: 59 nM

+

KDR, IC50: 77 nM

EGFR {[allProObj[0].p_purity_real_show]}
Linifanib ++++

VEGFR1/FLT1, IC50: 3 nM

++++

VEGFR2/KDR, IC50: 4 nM

+

VEGFR3/FLT4, IC50: 190 nM

FLT3 {[allProObj[0].p_purity_real_show]}
Vatalanib 2HCl +

VEGFR1/FLT1, IC50: 77 nM

++

VEGFR2/KDR, IC50: 37 nM

VEGFR2/Flk1, IC50: 270 nM

+

VEGFR3/FLT4, IC50: 660 nM

c-Kit,c-Fms {[allProObj[0].p_purity_real_show]}
Axitinib ++++

VEGFR1/FLT1, IC50: 0.1 nM

++++

VEGFR2/KDR, IC50: 0.2 nM

VEGFR2/Flk1, IC50: 0.18 nM

{[allProObj[0].p_purity_real_show]}
Dovitinib +++

VEGFR1/FLT1, IC50: 10 nM

+++

VEGFR2/Flk1, IC50: 13 nM

+++

VEGFR3/FLT4, IC50: 8 nM

c-Kit,FLT3 {[allProObj[0].p_purity_real_show]}
ZM 306416 +

VEGFR1, IC50: 0.33 μM

Src {[allProObj[0].p_purity_real_show]}
KRN-633 +

VEGFR1, IC50: 170 nM

+

VEGFR2, IC50: 160 nM

+

VEGFR3, IC50: 125 nM

c-Kit,BTK {[allProObj[0].p_purity_real_show]}
OSI-930 +++

FLT1, IC50: 8 nM

+++

KDR, IC50: 9 nM

{[allProObj[0].p_purity_real_show]}
Lenvatinib ++

VEGFR1/FLT1, IC50: 22 nM

++++

VEGFR2/KDR, IC50: 4.0 nM

+++

VEGFR3/FLT4, IC50: 5.2 nM

{[allProObj[0].p_purity_real_show]}
NVP-BAW2881 +

hVEGFR1, IC50: 820 nM

+++

hVEGFR2, IC50: 9 nM

mVEGF2, IC50: 165 nM

+

hVEGFR3, IC50: 420 nM

{[allProObj[0].p_purity_real_show]}
Cediranib +++

VEGFR1/FLT1, IC50: 5 nM

++++

VEGFR2/KDR, IC50: 0.5 nM

c-Kit {[allProObj[0].p_purity_real_show]}
Nintedanib ++

VEGFR1, IC50: 34 nM

+++

VEGFR2, IC50: 13 nM

+++

VEGFR3, IC50: 13 nM

FLT3 {[allProObj[0].p_purity_real_show]}
BMS-794833 ++

VEGFR2, IC50: 15 nM

{[allProObj[0].p_purity_real_show]}
SKLB1002 ++

VEGFR2, IC50: 32 nM

{[allProObj[0].p_purity_real_show]}
Cabozantinib S-malate ++++

VEGFR2/KDR, IC50: 0.035 nM

{[allProObj[0].p_purity_real_show]}
Ki8751 ++++

VEGFR2, IC50: 0.9 nM

c-Kit {[allProObj[0].p_purity_real_show]}
SU 5402 ++

VEGFR2, IC50: 20 nM

{[allProObj[0].p_purity_real_show]}
Rivoceranib Mesylate ++++

VEGFR2, IC50: 1 nM

RET {[allProObj[0].p_purity_real_show]}
Ponatinib ++++

VEGFR2, IC50: 1.5 nM

{[allProObj[0].p_purity_real_show]}
LY2874455 +++

VEGFR2, IC50: 7 nM

{[allProObj[0].p_purity_real_show]}
ZM323881 HCl ++++

VEGFR2, IC50: <2 nM

{[allProObj[0].p_purity_real_show]}
AZD2932 +++

VEGFR-2, IC50: 8 nM

c-Kit {[allProObj[0].p_purity_real_show]}
Cabozantinib ++++

VEGFR2/KDR, IC50: 0.035 nM

{[allProObj[0].p_purity_real_show]}
Sorafenib ++

VEGFR2, IC50: 90 nM

VEGFR2/Flk1, IC50: 90 nM

{[allProObj[0].p_purity_real_show]}
CYC-116 ++

VEGFR2, Ki: 44 nM

FLT3 {[allProObj[0].p_purity_real_show]}
Golvatinib ++

VEGFR2, IC50: 16 nM

{[allProObj[0].p_purity_real_show]}
Sunitinib +

VEGFR2 , IC50: 80 nM

FLT3 {[allProObj[0].p_purity_real_show]}
RAF265 ++

VEGFR2, EC50: 30 nM

{[allProObj[0].p_purity_real_show]}
PD173074 {[allProObj[0].p_purity_real_show]}
BFH772 ++++

VEGFR2, IC50: 3 nM

{[allProObj[0].p_purity_real_show]}
Semaxinib +

VEGFR2/Flk1, IC50: 1.23 μM

{[allProObj[0].p_purity_real_show]}
Vandetanib ++

VEGFR2, IC50: 40 nM

+

VEGFR3, IC50: 110 nM

EGFR {[allProObj[0].p_purity_real_show]}
SAR131675 ++

VEGFR3, IC50: 23 nM

{[allProObj[0].p_purity_real_show]}
ENMD-2076 +

VEGFR2/KDR, IC50: 58.2 nM

++

VEGFR3/FLT4, IC50: 15.9 nM

RET,FLT3 {[allProObj[0].p_purity_real_show]}
Telatinib +++

VEGFR2, IC50: 6 nM

++++

VEGFR3, IC50: 4 nM

c-Kit {[allProObj[0].p_purity_real_show]}
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

BAX-IN-1 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.26mL

0.65mL

0.33mL

16.32mL

3.26mL

1.63mL

32.65mL

6.53mL

3.26mL

BAX-IN-1 技术信息

CAS号331261-91-7
分子式C16H14N6O
分子量 306.322
别名
运输蓝冰
存储条件

粉末 Keep in dark place,Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度
动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。